Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds 
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
New York Declares Measles Disaster Emergency as Cases Surge 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
U.S. Issues Cuba Health Alert as Illnesses Rise 
3 clinical-grade skincare creams you really shouldn’t buy online 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Add as a preferred source on Google
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 42 companies including many key and niche players such as
- Abbott Laboratories, Inc. (US)
- Abbott Molecular, Inc. (US)
- Adaltis S.r.l. (Italy)
- Alere (US)
- Beckman Coulter, Inc. (US)
- bioMérieux SA (France)
- Bio-Rad Laboratories, Inc. (US)
- Calypte Biomedical Corporation (US)
- Chembio Diagnostic Systems, Inc. (US)
- Hologic, Inc. (US)
- Fujirebio Europe N.V. (Belgium)
- MedMira Inc. (Canada)
- OraSure Technologies, Inc. (US)
- Ortho-Clinical Diagnostics, Inc. (US)
- Quest Diagnostics, Inc. (US)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare Diagnostics, Inc. (US)
- Trinity Biotech Plc. (Ireland)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. GROWTH DRIVERS AND MARKET TRENDS
3. HIV/AIDS STATISTICS
4. HIV/AIDS: UNDERSTANDING THE DISEASE
5. DIAGNOSIS OF HIV/AIDS
6. PRODUCT APPROVALS & LAUNCHES
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47)
- The United States (33)
- Canada (2)
- Europe (8)
- - France (2)
- - Italy (2)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/cq3kt5/hivaids_testing
CONTACT: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Infectious Disease Testing
